SMLR vs. CDRE, LQDA, INMD, PLSE, BLFS, AORT, MDXG, RXST, FNA, and BFLY
Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Cadre (CDRE), Liquidia (LQDA), InMode (INMD), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Artivion (AORT), MiMedx Group (MDXG), RxSight (RXST), Paragon 28 (FNA), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry.
Semler Scientific vs.
Cadre (NYSE:CDRE) and Semler Scientific (NASDAQ:SMLR) are both small-cap industrial products companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, community ranking, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.
Semler Scientific has a net margin of 72.65% compared to Cadre's net margin of 6.34%. Semler Scientific's return on equity of 50.77% beat Cadre's return on equity.
44.0% of Cadre shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 37.0% of Cadre shares are owned by company insiders. Comparatively, 30.2% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Cadre has higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.
Cadre received 14 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 66.67% of users gave Semler Scientific an outperform vote while only 55.17% of users gave Cadre an outperform vote.
Cadre has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500.
In the previous week, Semler Scientific had 7 more articles in the media than Cadre. MarketBeat recorded 8 mentions for Semler Scientific and 1 mentions for Cadre. Semler Scientific's average media sentiment score of 0.80 beat Cadre's score of 0.70 indicating that Semler Scientific is being referred to more favorably in the news media.
Cadre currently has a consensus price target of $39.67, suggesting a potential upside of 17.76%. Semler Scientific has a consensus price target of $71.00, suggesting a potential upside of 48.72%. Given Semler Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Semler Scientific is more favorable than Cadre.
Summary
Semler Scientific beats Cadre on 11 of the 18 factors compared between the two stocks.
Get Semler Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Semler Scientific Competitors List
Related Companies and Tools
This page (NASDAQ:SMLR) was last updated on 2/22/2025 by MarketBeat.com Staff